Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spire Healthcare GroupCHIX:SPIL 73 Days Sales Outstanding is 20.07 as of Dec. 2025, which is 14% above its 10-year median of 17.54. GuruFocus rates CHIX:SPIL with a GF Score™ of 73/100 and a GF Value™ of £2.71 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 662 Healthcare Providers & Services companies, Spire Healthcare Group ranks better than 81.72% on this metric.
The historical rank and industry rank for Spire Healthcare Group's Days Sales Outstanding or its related term are showing as below:
CHIX:SPIl'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 13.31 Med: 17.54 Max: 28.01
Current: 19.66
During the past 13 years, Spire Healthcare Group's highest Days Sales Outstanding was 28.01. The lowest was 13.31. And the median was 17.54.
CHIX:SPIl's Days Sales Outstanding is ranked better than 81.72% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: 45.825
vs CHIX:SPIl: 19.66
Spire Healthcare Group's Days Sales Outstanding
declined
from Dec. 2024 (20.72) to Dec. 2025 (20.07).
Spire Healthcare Group (CHIX:SPIl) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Spire Healthcare Group Days Sales Outstanding Related Terms
Spire Healthcare Group Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Spire Healthcare Group's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group Days Sales Outstanding Chart
CHIX:SPIL vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Spire Healthcare Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's Days Sales Outstanding falls into.
Spire Healthcare Group Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group (CHIX:SPIL) has a Days Sales Outstanding of 20.07 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Spire Healthcare Group and its competitors. This is 14% above median its historical median of 17.54. Over the past decade, Spire Healthcare Group's Days Sales Outstanding has ranged from 13.31 to 28.01. According to the industry distribution chart, Spire Healthcare Group ranks #121 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 18.3%.
Is Spire Healthcare Group's Days Sales Outstanding too high?
Spire Healthcare Group's current Days Sales Outstanding of 20.07 is 14% above median its 10-year median of 17.54. Over the past 10 years, this metric has ranged from a low of 13.31 to a high of 28.01. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.83. Spire Healthcare Group's value of 20.07 is 56.2% below this industry median. Based on the distribution chart, Spire Healthcare Group ranks #121 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Spire Healthcare Group has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #121 out of 662 companies for Days Sales Outstanding. This places Spire Healthcare Group in the top 18% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.83. Spire Healthcare Group's value of 20.07 is 56.2% below this benchmark. Historically, Spire Healthcare Group's own Days Sales Outstanding has ranged from 13.31 to 28.01 over the past decade. While the company's 10-year median is 17.54 vs. the industry median of 45.83, Spire Healthcare Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.83, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current Days Sales Outstanding of 20.07 is 56.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current Days Sales Outstanding is 20.07, which is 14% above median its own 10-year median of 17.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.71, compared to a current price of £2.36 — trading 12.9% below its estimated fair value. The current Days Sales Outstanding is 20.07, which is 14% above median its 10-year median of 17.54 and 56.2% below the Healthcare Providers & Services industry median of 45.83. Spire Healthcare Group's overall GF Score™ is 73/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current Days Sales Outstanding is 20.07 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.36 is trading 12.9% below its estimated GF Value™ of £2.71.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
Days Sales Outstanding: 20.07 (14% above median its 10-year median of 17.54)
GF Value™: £2.71 vs. price of £2.36 (12.9% below fair value)
Industry Position: 56.2% below the Healthcare Providers & Services median (#121 of 662)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
73GF Score
Get the complete analysis for CHIX:SPIL
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
